Additional file 2: of Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers

Table S1. Differentially expressed genes in CD133 + −vs.-CD133- gastric cancer cell lines. A total of 177 and 129 up- and down-regulated genes (SNR > 1.0 and SNR < − 1.0, respectively) in CD133+ cells compared to CD133- cells are listed with gene symbol and SNR. Type indicates whether the genes are up- or down-regulated in CD133_ cells. Additional information including the RefSeq ID, chromosome and gene descriptions are also shown. Table S2. Primers sequence of reverse transcription polymerase chain reaction. Primers of up-regulated CDC2 gene and down-regulated ARG1 genes in CD133+ cells are listed. Table S3. GO categories enriched with CD133 signature genes. The GO terms substantially enriched (P < 0.01; Fisher’s exact test) are listed for their categories (whether enriched in CD133+ up- or down-regulated genes). The number of genes in GO terms are Gene Size and the overlapping CD133 signature genes are DEG. Significance from Fisher’s exact test is P value. Table S4. Correlation of CD133 signature and clinicopathological features in GC. A total of 34 features were evaluated with CD133 signature as available in TCGA consortium. The types of statistical tests, significance level and the classes used for the tests are listed. Table S5. CIS signature. 36 genes were selected as those appeared at least twice in three CD133/stemness-related signatures. (XLSX 45 kb)